Unknown PHASE2 INTERVENTIONAL NCT00107055

Study of REN-1654 in Patients With Sciatica Pain

REN-1654 in Sciatica: A Phase 2, Randomized, Double-Blind, Placebo Controlled, Multi-Center Study in Subjects With Pain Due to Lumbosacral Radiculopathy

Sponsor: Renovis

Conditions Herniated Disc Radiculopathy Sciatica

Interventions REN-1654

Updated 7 times since 2017 Last updated: Jun 23, 2005 Started: Dec 31, 2003 Completion: Apr 30, 2005

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Herniated Disc and Radiculopathy and is currently ongoing. Renovis leads this study, which shows 7 recorded versions since 2003 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Jan 2026 — Present [monthly]

Unknown PHASE2
Sep 2025 — Present [monthly]

Unknown PHASE2
Sep 2024 — Sep 2025 [monthly]

Unknown PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE2

▶ Show 2 earlier versions

Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE2
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE2

First recorded

Dec 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Renovis

Data source: Renovis

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Allentown, United States , Asheville, United States , Atlanta, United States , Austin, United States , Birmingham, United States , Boston, United States , Clearwater, United States , Cleveland, United States , Denver, United States , New York, United States and 8 more locations